David Weiss is a partner with the life sciences practice. He has more than 12 years of industry experience supporting multiple brands across a wide variety of functional areas. David brings extensive experience in both corporate and commercial strategy, product launch and brand planning, LCM strategy, market research, commercial excellence, and consultative selling. He’s been a key contributor to several blockbuster products across a diverse set of therapeutic areas, including 10 product launches.
Prior to joining Guidehouse, David spent three years working at Amgen within their Bone Health Business Unit where he focused on the launch of Prolia (denosumab), a novel monoclonal antibody. Before Amgen, David spent almost six years at Wyeth Pharmaceuticals (Pfizer) in several different field positions including significant time spent in the Women’s Healthcare and Neuroscience divisions.
This update is now brought to you by the Guidehouse Center for Health Insights, a complete view of payment, operational, and consumer disruption insights and solutions.